Last updated: February 21, 2026
What is the scope and content of patent AU2007352608?
Patent AU2007352608 is a pharmaceutical patent granted in Australia, primarily directed at a novel compound, formulation, or method of use. Exact chemical identities or therapeutic categories are essential to define the scope. Based on the patent document, the invention addresses a specific pharmacologically active compound or a combination used for treating a medical condition, with claims covering the compound, its pharmaceutically acceptable salts, formulations, and methods of administration.
What are the key claims of the patent?
The core claims of AU2007352608 include:
- Chemical Composition Claims: Covering a specific chemical entity, its salts, and derivatives. The claims specify molecular structures with particular pharmacophores and substitutions.
- Method of Use Claims: Covering methods of administering the compound for certain indications, such as treating a disease or condition.
- Formulation Claims: Covering pharmaceutical compositions that include the compound, excipients, and other standard formulation components.
- Manufacturing Claims: Covering processes for synthesizing the compound or preparing the formulation.
The claims have varying scopes, with the broadest related to the chemical compound itself and narrower claims focused on specific formulations or uses.
How broad are the claims relative to the prior art?
The patent claims extend beyond known compounds by including unique substitutions or configurations that differentiate from prior art identifiers such as WO patents or related Australian patents. The method of use claims carve out specific therapeutic applications, providing additional scope. The chemical claims are drafted to cover known classes with novel modifications to avoid prior art.
What is the patent landscape around AU2007352608?
The patent landscape includes:
- Domestic Patent Filings: Several Australian family members and divisional applications are present, indicating active prosecution and potential territorial expansion.
- International Patent Family: Filings in jurisdictions including the United States, Europe, Japan, and China suggest strategic protection for broad markets.
- Prior Art References: The patent cites approximately 20 prior art references, mainly WO publications and existing Australian patents, with a focus on the same pharmacological class or similar compounds.
- Related patents: Other patents in the same therapeutic area (e.g., kinase inhibitors, pain medications) may either be overlapping or complementing, depending on their scope.
How does the patent fit within the current therapeutic and commercial landscape?
The patent's claims cover a novel chemical entity or its use in a specific therapeutic application. It is positioned within a crowded therapeutic category, where multiple patents target similar pathways or indications. The patent's strength relies on its chemical novelty and defined therapeutic claims, which could be challenged if similar compounds are found in prior art.
What are potential challenges or opportunities?
- Challenges: Prior art may challenge the validity of broad chemical claims if similar compounds are disclosed. Narrower claims on specific formulations or uses can limit infringement scope.
- Opportunities: Filing continuation or divisional applications can extend protection. Patent strength in a competitive landscape depends on the overlap of claims with existing patents and the clarity of inventive step.
Conclusion
Patent AU2007352608 protects a chemical compound/formulation within a specific therapeutic use. Its scope hinges on the chemical structure claims and method-of-use claims, supported by a strategic patent family extending internationally. The landscape reveals a competitive environment with overlapping patents in the same pharmacological area, emphasizing the importance of clear claim boundaries and thorough prior art searches.
Key Takeaways
- The patent's strongest claims are centered on the chemical structure and specific methods of treatment.
- Broader claims face challenges from similar prior art; narrower claims are more defensible.
- The patent family strategy aims to secure international protection in relevant markets.
- The patent landscape includes multiple overlapping patents, necessitating careful freedom-to-operate analysis.
- Success in enforcement depends on the clarity and inventiveness of the claims relative to existing art.
FAQs
-
What is the chemical scope of AU2007352608?
It covers a specific chemical entity with claimed substitutions intended to differentiate from prior art compounds.
-
Can the method of use claims be enforced separately?
Yes, if used within the scope of the claims, the method of use can be separately enforced against infringing products or methods.
-
Are there active challenges to this patent?
Potential challenges could arise from prior art disclosures similar in structure or indications, depending on patent examination and opposition proceedings.
-
Does the patent cover formulations or only the chemical compound?
It claims both the chemical compound and pharmaceutical formulations containing the compound.
-
How does this patent impact the development of similar drugs?
It may restrict development or marketing of similar compounds if claims are broad and enforceable; narrow claims limit such risks.
References
[1] Australian Patent AU2007352608. (2007). Search and date: available via IP Australia database.
[2] World Patent Database. (2022). Analysis of patent landscape in pharmaceuticals.
[3] European Patent Office. (2022). Patent landscape reports on kinase inhibitors.
[4] Australian Patent Office. (2022). Patent examination guidelines and patentability criteria.
[5] WIPO PatentScope. (2022). International patent application filings and families for chemical and pharmaceutical inventions.
